FIRST TRACKS BIOTHERAPEUTICS, INC. Diluted Shares Outstanding (Weighted Average)
FIRST TRACKS BIOTHERAPEUTICS, INC. (TRAX) reported Diluted Shares Outstanding (Weighted Average) of 35.00 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-12
- FIRST TRACKS BIOTHERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 35.00M shares, a 21.50% increase year-over-year.
- FIRST TRACKS BIOTHERAPEUTICS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2025-06-30 was 28.81M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month |
|---|---|---|
| 2026-06-30 | 35.00M shares 10-Q · filed 2026-08-12 | 35.00M shares 10-Q · filed 2026-08-12 |
| 2025-06-30 | 28.81M shares 10-Q · filed 2026-08-12 | 29.72M shares 10-Q · filed 2026-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |